CN Patent

CN102952144A — 阿森纳平马来酸盐的晶型、制备方法及其药物组合物

Assigned to Shanghai Huatuo Medical Science Co Ltd · Expires 2013-03-06 · 13y expired

What this patent protects

本发明公开了阿森纳平马来酸盐的晶型、制备方法及其药物组合物。所述的阿森纳平马来酸盐的晶型A和B晶型稳定，微粉化性能强，微粉化后在水体系中具有良好的溶出度，适合与常规药用辅料制成药物组合物，用于制备具有优良溶出度的口服固体制剂。

USPTO Abstract

本发明公开了阿森纳平马来酸盐的晶型、制备方法及其药物组合物。所述的阿森纳平马来酸盐的晶型A和B晶型稳定，微粉化性能强，微粉化后在水体系中具有良好的溶出度，适合与常规药用辅料制成药物组合物，用于制备具有优良溶出度的口服固体制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102952144A
Jurisdiction
CN
Classification
—
Expires
2013-03-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Huatuo Medical Science Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.